Literature DB >> 19561483

Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy.

Daniele Marrelli1, Corrado Pedrazzani, Giovanni Corso, Alessandro Neri, Marianna Di Martino, Enrico Pinto, Franco Roviello.   

Abstract

OBJECTIVE: To compare clinicopathological features and long-term outcome in gastric cancer patients coming from high-risk and low-risk areas of Italy. SUMMARY BACKGROUND DATA: Better survival rates have been reported from countries with higher incidence of gastric cancer.
METHODS: Data regarding 829 patients coming from Tuscany (group A) and 143 patients coming from Southern Italy (group B) were analyzed. Mean follow-up time was 56 +/- 57 months; it was 85 +/- 63 months in surviving patients or not tumor-related deaths. Prognostic factors were investigated by multivariate analysis with Cox proportional hazard model after verifying the assumption of proportionality of the risk associated with covariates.
RESULTS: Lauren diffuse-mixed histotype, younger age, extended lymphadenectomy, and advanced stages were more common in group B. Gastric cancer-related 10-year survival probability was 48% in group A versus 29% in group B (log-rank test: P < 0.001). By multivariate analysis, geographic area was confirmed as a significant prognostic factor (hazard ratio for group B vs. group A: 1.52, 95% confidence interval: 1.12-2.06, P = 0.006). The influence of this factor on long-term survival was independent from other clinical, surgical, and pathologic factors, and was notable in neoplasms involving the serosa (10-year survival probability: 15% in group A vs. 3% in group B, log-rank test: P = 0.005).
CONCLUSIONS: Patients coming from low-risk area of Italy showed distinct pathologic features, more advanced stage, and worse prognosis when compared with patients coming from high-risk area. These findings may be indicative of different tumor biology, and may contribute to partly explain worldwide geographic variability in prognosis reported in different series.

Entities:  

Mesh:

Year:  2009        PMID: 19561483     DOI: 10.1097/SLA.0b013e3181ad6487

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  Log-normal censored regression model detecting prognostic factors in gastric cancer: a study of 3018 cases.

Authors:  Bin-Bin Wang; Cai-Gang Liu; Ping Lu; A Latengbaolide; Yang Lu
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

2.  Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability?

Authors:  Daniele Marrelli; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

Review 3.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Gastric linitis plastica: which role for surgical resection?

Authors:  Corrado Pedrazzani; Daniele Marrelli; Fabio Pacelli; Maria Di Cosmo; Gianni Mura; Francesca Bettarini; Fausto Rosa; Giovanni de Manzoni; Franco Roviello
Journal:  Gastric Cancer       Date:  2011-06-30       Impact factor: 7.370

5.  High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.

Authors:  Karol Polom; Daniele Marrelli; Valeria Pascale; Giandomenico Roviello; Costantino Voglino; Henry Rho; Carla Vindigni; Mario Marini; Raffaele Macchiarelli; Franco Roviello
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-20       Impact factor: 4.553

6.  Effect of complication grade on survival following curative gastrectomy for carcinoma.

Authors:  Nan Jiang; Jing-Yu Deng; Xue-Wei Ding; Li Zhang; Hong-Gen Liu; Yue-Xiang Liang; Han Liang
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 7.  Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.

Authors:  Giovanni Corso; Daniele Marrelli; Valeria Pascale; Carla Vindigni; Franco Roviello
Journal:  BMC Cancer       Date:  2012-01-06       Impact factor: 4.430

8.  Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.

Authors:  Phillip Stahl; Carsten Seeschaaf; Patrick Lebok; Asad Kutup; Maximillian Bockhorn; Jakob R Izbicki; Carsten Bokemeyer; Ronald Simon; Guido Sauter; Andreas H Marx
Journal:  BMC Gastroenterol       Date:  2015-02-05       Impact factor: 3.067

Review 9.  Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.

Authors:  Xiaohua Ye; Jinjian Fu; Yi Yang; Yanhui Gao; Li Liu; Sidong Chen
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

10.  Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.

Authors:  Jiuda Zhao; Feng Du; Yu Zhang; Jie Kan; Li Dong; Guoshuang Shen; Fangchao Zheng; Hui Chen; Junhui Zhao; Faxiang Ji; Yang Luo; Fei Ma; Ziyi Wang; Binghe Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.